Zobrazeno 1 - 10
of 19
pro vyhledávání: '"antoine salloum"'
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:QIM23-137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbfa0b7e0704ee32c22ca97cb8be4027
https://doi.org/10.6004/jnccn.2022.7185
https://doi.org/10.6004/jnccn.2022.7185
Autor:
Nagham Bazzi, Antoine Salloum, Joanna Abi Chebl, Walid Hreibe, Mariam Bazzi, Elias Fiani, Anthony Benedetto, Mohamad Moussa
Publikováno v:
International Journal of Dermatology. 61:1364-1371
Juvenile gangrenous vasculitis of the scrotum (JGVS) is a rare entity with scant reports in the literature. The disease course, treatment, and prevalence have not been well described in the literature. It's hypothesized that JGVS is a variant of pyod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d9e7a4a528b232697437099c883f93
https://doi.org/10.1111/ijd.16066
https://doi.org/10.1111/ijd.16066
Autor:
Antoine Salloum, Nagham Bazzi, Stephen Squires, Thomas Chu, Paul Benedetto, Anthony Benedetto
Publikováno v:
Journal of cosmetic dermatologyREFERENCES.
Xenografts are a now a cornerstone in the management of wound dressings. Promising results were achieved since 1960 in the application of skin substitute for skin defects.The objective of this study was to evaluate the efficacy of various xenografts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9194826cdef54ddbf8f66837fc4b83dc
https://pubmed.ncbi.nlm.nih.gov/36409467
https://pubmed.ncbi.nlm.nih.gov/36409467
Publikováno v:
Journal of Cosmetic Dermatology
Introduction In December 2019, a new coronavirus has emerged out of China, the SARS-CoV-2 virus, causing a disease known as COVID-19, which steadily has progressed into a pandemic. This coronavirus affects many organs, including the skin, whose manif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d465b248d6290fbf81df4aaa65ff9d23
https://doi.org/10.1111/jocd.14266
https://doi.org/10.1111/jocd.14266
Publikováno v:
Australasian Journal of Dermatology. 62:421-426
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::034ef38c367a4defe747d5899767d808
https://doi.org/10.1111/ajd.13646
https://doi.org/10.1111/ajd.13646
Publikováno v:
Journal of Cosmetic Dermatology. 21:339-342
INTRODUCTION Safeguarding the integrity of the donor site during the initial suspension phase of an interpolation flap is difficult. There are a variety of approaches and no consensus on post-operative management of the donor site or pedicle followin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94fa4b74cdbf60fef54f65dc4ecf5f4b
https://doi.org/10.1111/jocd.14082
https://doi.org/10.1111/jocd.14082
Publikováno v:
Journal of Cosmetic Dermatology. 20:1073-1079
Background Proton-pump inhibitors (PPIs) are one of the most prescribed drugs. Their dermatological adverse reactions are multiple and vary in severity. Aims This review discusses all reported cutaneous side effects of PPIs in order to help physician
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d391948cc241361b713061277489cd0
https://doi.org/10.1111/jocd.13763
https://doi.org/10.1111/jocd.13763
Autor:
Antoine Salloum, Maya Habre, Joanna Abi Chebl, Karen Abi Chebl, Carl Atallah, Georgio Medawar, Hampig R Kourie
Publikováno v:
Immunotherapy. 14(6)
Aim: This paper presents the reported dermatological adverse events (AEs) associated with approved combinations of immunotherapy with drugs of the same class, or in combination with targeted therapy or chemotherapy. Materials & methods: PubMed was us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d337754711bf1a46e8b5ff620a45e94
https://pubmed.ncbi.nlm.nih.gov/35232283
https://pubmed.ncbi.nlm.nih.gov/35232283
Publikováno v:
J Clin Aesthet Dermatol
Scopus-Elsevier
Scopus-Elsevier
BACKGROUND: Talimogene laherparepvec (T-VEC) is the first oncolytic virus therapy approved by the United States Food and Drug Administration (in 2015) for the treatment of advanced-stage melanoma. Despite a paucity of Phase III trials for T-VEC as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3e6e1d421494147ceed6ddcd7d648f11
https://europepmc.org/articles/PMC8675341/
https://europepmc.org/articles/PMC8675341/
Publikováno v:
The American Journal of Case Reports
Patient: Female, 77-year-old Final Diagnosis: Atypical bullous pemphigoid Symptoms: Bullous skin lesions Medication: — Clinical Procedure: — Specialty: Dermatology Objective: Unusual clinical course Background: Bullous pemphigoid is a common prur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d103cab79f1d083a09da815592c884a3
https://pubmed.ncbi.nlm.nih.gov/34584063
https://pubmed.ncbi.nlm.nih.gov/34584063